Among the nearly 50 disease mutations in the gene for the catalytic subunit of human DNA polymerase g, POLG, the A467T substitution is the most common and has been found in 0.6% of the Belgian population. The A467T mutation is associated with a wide range of mitochondrial disorders, including Alpers syndrome, juvenile spino-cerebellar ataxia-epilepsy syndrome, and progressive external ophthalmoplegia, each with vastly different clinical presentations, tissue specificities, and ages of onset. The A467T mutant enzyme possesses only 4% of wildtype DNA polymerase activity, and the catalytic defect is manifest primarily through a 6-fold reduction in k cat with minimal effect on exonuclease function. Human DNA polymerase g (pol g) requires association of a 55 kDa accessory subunit for enhanced DNA binding and highly processive DNA synthesis.
Among the nearly 50 disease mutations in the gene for the catalytic subunit of human DNA polymerase g, POLG, the A467T substitution is the most common and has been found in 0.6% of the Belgian population. The A467T mutation is associated with a wide range of mitochondrial disorders, including Alpers syndrome, juvenile spino-cerebellar ataxia-epilepsy syndrome, and progressive external ophthalmoplegia, each with vastly different clinical presentations, tissue specificities, and ages of onset. The A467T mutant enzyme possesses only 4% of wildtype DNA polymerase activity, and the catalytic defect is manifest primarily through a 6-fold reduction in k cat with minimal effect on exonuclease function. Human DNA polymerase g (pol g) requires association of a 55 kDa accessory subunit for enhanced DNA binding and highly processive DNA synthesis.
However, the A467T mutant enzyme failed to interact with, and was not stimulated by, the accessory subunit, as judged by processivity, heat inactivation, and Nethylmaleimide protection assays in vitro. Thermolysin digestion and immunoprecipitation experiments further indicate weak association of the subunits for A467T pol g. This is the first example of a mutation in POLG that disrupts physical association of the pol g subunits.
W e propose that reduced polymerase activity and loss of accessory subunit interaction are responsible for the depletion and deletion of mitochondrial DNA observed i n patients with this POLG mutation.
DNA polymerase g (pol g)
1 is the only DNA polymerase found in animal cell mitochondria and thus bears sole responsibility for DNA synthesis in all replication and repair transactions involving mitochondrial DNA (mtDNA) (1) . Depletion of mtDNA, as well as the accumulation of deletions and point mutations in mtDNA during aging have been observed in several human disorders (reviewed in (2) ). Mutations in the gene for the catalytic subunit of pol g, POLG, are linked with a wide variety of mitochondrial diseases, including dominant and recessive forms of progressive external ophthalmoplegia (PEO), Alpers syndrome, Parkinsonism, juvenile spinocerebellar ataxia-epilepsy syndrome (SCAE), as well as sensory ataxia, neuropathy, dysarthria and ophthalmoparesis (SANDO) and even male infertility (3,4).
The G-to-A mutation at nucleotide 1399 in exon 7 of POLG, which causes an alanine to threonine amino acid substitution at codon 467, is the most common disease mutation found in POLG associated with Alpers syndrome, SCAE and autosomal recessive PEO (arPEO) (5) (6) (7) (8) (9) (10) (11) (12) . The A467T mutation occurs at a frequency of 0.6% in the Belgian population and exhibits autosomal recessive transmission in PEO, as heterozygous people are asymptomatic with no clinical signs of disease (7) . PEO is a mitochondrial disorder associated with the accumulation of point mutations and deletions within mtDNA that causes progressive weakness of the external eye muscles (13, 14) . In Alpers syndrome, the A467T mutation is either homozygous or paired in trans with other mutations in POLG in compound heterozygotes (9, 11) .
Alpers syndrome is a fatal early childhood disease characterized by psychomotor retardation, hepatic failure and intractable seizures, as well as tissue-specific mtDNA depletion. The age of onset of Alpers syndrome is generally the first few months to years of life.
Animal cell pol g is a two subunit complex consisting of a 140 kDa catalytic subunit (p140) and a 55 kDa accessory subunit (p55). The catalytic subunit is a family A DNA polymerase, which includes bacterial Pol I and T7 DNA polymerase, and p140 possesses DNA polymerase, 3'-5' exonuclease, and 5'-dRP lyase activities. The 55 kDa accessory subunit (p55) is required for processive DNA synthesis and tight binding of the pol g complex to DNA. Significant amino acid sequence homology between p140 and T7 DNA polymerase allowed us to build a structural homology model of the human pol g active site (15, 16) . Whereas T 7 DNA polymerase becomes highly processive upon binding E. coli thioredoxin in a stable oneto-one complex (17, 18) , pol g achieves high processivity by binding the p55 subunit (19) . Ala467 is highly conserved across species and resides within the linker region between the exonuclease and polymerase domains of p140, but still in close linear proximity to the conserved exonuclease motifs (Fig. 1) . Although this linker region has only limited amino acid conservation with T7 DNA polymerase, the crystal structure of T7 DNA polymerase places the position analogous t o Ala467 in an extended loop between helices H and H1 that is necessary for binding thioredoxin (20) . A deletion mutagenesis study of the Drosophila pol g catalytic subunit suggested that the exonuclease region, as well as part of the linker region, may be responsible for subunit interaction (21) . Also, the YED mutant of Drosophila pol g, located only 13 amino acids prior to the homologous Ala467 site, exhibits a 40% reduction in processivity, further suggesting that this region participates in subunit interaction (22) .
We undertook this study to investigate the biochemical mechanisms by which the A467T substitution in the catalytic subunit contributes to pathology. Biochemical characterization demonstrated compromised catalytic activity of A467T p140. Additional functional and physical analyses, including processivity, heat inactivation, Nethylmaleimide (NEM) protection, thermolysin digestion, and immunoprecipitation (IP) assays revealed a failure of A467T p140 to interact with the accessory subunit. We propose that these deficiencies are most likely responsible for the depletion and deletion of mtDNA in patients with this mutation.
Experimental Procedures
Expression and purification--The cDNAs for wild-type (WT) and exonuclease -deficient (Exo -) forms of the His 6 affinity-tagged recombinant catalytic subunit of human pol g were expressed in baculovirus-infected Sf9 cells (23) , and the proteins were purified t o homogeneity as described previously (15) . The His 6 affinity-tagged p55 accessory subunit was expressed in E. coli and purified to homogeneity as described previously (19) .
The A467T mutant derivative of p140 was constructed in two steps. First, the Exo -pQVSL11.4 baculoviral transfer vector encoding p140 Exo -without its mitochondrial targeting sequence (24) was converted to the A467T derivative with the QuikChange site-directed mutagenesis kit (Stratagene) and the mutagenic primers 5'-TTG ATG GAT CTG ACC AAT GAT GCC TGC-3' and 5'-GCA GGC ATC ATT GGT CAG ATC CAT CAA-3'. This A467T p140 Exo -cDNA was reverted back to exonuclease proficiency (23) in a second QuikChange cycle using the mutagenic primers 5'-GCC CTG GTG TTC GAC GTG GAG GTC TGC TTG GC-3' and 5'-CTG CAA GCA GAC CTC CAC GTC GAA CAC CAG GGC-3'. The A467T mutation and exonuclease proficient status were confirmed by DNA sequencing of the baculovirus transfer vector. Recombinant baculoviruses expressing the A467T mutant pol g catalytic subunit were selected and amplified, and Sf9 insect cells from 30 confluent T 175 tissue culture flasks were transfected for protein expression and processed as described previously (15, 23) .
MonoQ fractions containing A467T p140 were frozen in small aliquots in liquid nitrogen and stored at -80˚C. Enzymatic assays--DNA polymerase activity was determined in our standard pol g assay with poly(rA)-oligo(dT) [12] [13] [14] [15] [16] [17] [18] (Amersham Biosciences) as the template-primer substrate (19) . Steady state kinetic values were determined with this standard assay, as previously described (25) . The K m(DNA) was measured on poly(dA)-oligo(dT) [12] [13] [14] [15] [16] [17] [18] (Amersham Biosciences) as described (19) with 0.85 nM WT and 16 nM A467T enzyme and 0.25-40 mM oligo(dT)-primer ends. The K d(DNA) was determined using a gel mobility-shift assay as previously described (26) . The two subunit form of pol g was reconstituted as described, and reactions with and without p55 were carried out at optimal salt conditions (19) . The processivity of WT and A467T mutant forms of pol g were estimated by primer extension assay on an end-labeled, singly primed M13 DNA substrate as described, except the pre-incubation step was eliminated, reaction times were 20 minutes, and identical reactions were assembled both with and without a DNA trap (19) . Exonuclease activity was determined by monitoring degradation of a 5'-3 2 P endlabeled, gel-purified 40mer oligonucleotide (5'-TCA CTG ATA TAC GTC CGA CTC TGA TGT ACA TGG TCA TGG T-3'). Reaction mixtures (10 mL) contained 25 mM HEPES-KOH, pH 7.6, 1 mM 2-mercaptoethanol, 5 mM MgCl 2 , 0.05 mg/mL heat-treated BSA, 10 mM NaCl, 5 pmol of the labeled oligonucleotide, and 0.4-3.5 nM purified WT p140 or A467T p140. Following incubation at 37˚C for 10 min, reactions were terminated and products were analyzed by denaturing polyacrylamide gel electrophoresis, as described (23) . Products were quantified with a Typhoon 9400 PhosphorImager (Molecular Dynamics) and NIH Image 1.63 software. Thermolysin digestion and immunoblot analysis--In a final volume of 20mL, WT p140 (1.1 mg) and A467T p140 (0.61 mg), with and without the addition of a 2-fold molar excess of the p55 accessory subunit, were partially digested with thermolysin at 37˚C, 52˚C and 60˚C for 30 minutes, based on the method of Polesky et al. (27) . Pol g and its degradation products were resolved on 4-20% Tris-glycine-SDS gels (Novex) and electrotransferred t o Immobilon-P PVDF membranes (Millipore). Immunoblots were processed as described previously using p140-specific rabbit antisera (23) . Immunoprecipitation assay--Rabbit polyclonal antibodies (DPg) against recombinant pol g (23) were immobilized on Protein G Sepharose beads (Amersham Biosciences), and the beads were then equilibrated in PBSN-BSA buffer consisting of 0.05 M KPO 4 , pH7.5, 0.15 M NaCl, 0.1% NP-40, and 0.1 mg/mL BSA. Prepared DPgProtein G-Sepharose beads (10 mL) were mixed with purified WT pol g (3 mg), A467T mutant pol g (3 mg), and/or the p55 accessory subunit (3 mg), as indicated, in a 1.5 mL polypropylene microfuge tube and brought to a final volume of 0.4 mL with PBSN-BSA. Tubes were rotated end-over-end for 45 min at 4˚C, and beads were collected by microcentrifugation at 5000 rpm for 2 min at 4˚C. The supernatant was removed and beads were washed twice with PBSN-BSA and once with PBSN lacking BSA. Beads were resuspended in 25 mL 2x LDS loading buffer (4x LDS loading buffer from Invitrogen, made 2x with PBSN lacking BSA), and the samples were heated for 10 min at 70˚C prior to analysis on 4-12% NuPage Bis-Tris polyacrylamide gels (Invitrogen).
This combination of loading buffer and polyacrylamide gel helped t o minimize background due to cross-reactivity with rabbit immunoglobin heavy chains. After electrophoresis, the proteins were electrotransferred to an Immobilon-P PVDF membrane (Millipore). The membrane was then washed in TNT (0.1% Triton X-100, 50 mM Tris-HCl, pH7.5, 0.5 M NaCl) for 15 min and blocked with 5% dried milk in TN (50 mM TrisHCl, pH7.5, 0.5 M NaCl) at room temperature. The blot was incubated with 0.2 mg/mL antiPenta-His monoclonal antibody (Qiagen) in T N containing 0.1 mg/mL BSA for 2 hr, washed 3 times with TN for 10 min, and incubated in a 1/3000 dilution of goat anti-mouse alkaline phosphatase conjugated secondary antibody (Bio-Rad) for 1 hr. Following three 10 min washes in TNT and three 10 min washes in TN, bands were visualized with Western Blue reagent (Promega).
RESULTS

A467T substitution reduces polymerase activity
To study the biochemical properties of the A467T pol g variant commonly found in Alpers syndrome, SCAE and PEO, we made the A467T substitution by site-directed mutagenesis and overproduced the mutant protein in baculovirus-infected insect cells. Expression and overall yield of recombinant A467T p140 were similar to those for WT p140 (23) , and the purity of the purified mutant enzyme approached 90% homogeneity.
Immunoblot analysis confirmed the identity of full-length A467T p140 and revealed minimal proteolytic degradation. Routine assays indicated reduced DNA polymerase activity, so the enzymatic activities of A467T p140 were examined more by guest on October 30, 2017 http://www.jbc.org/ Downloaded from critically by steady state kinetic analysis (Table  I) . In comparison to WT p140, the A467T substitution increased the K m for the incoming dNTP by a factor of 5 while reducing the k cat for DNA synthesis by almost 6-fold. As judged by the ratio of k cat /K m , the A467T substitution reduced overall efficiency of DNA synthesis t o <4% of WT activity. In contrast, exonuclease activity was only decreased ~2-fold by the A467T substitution (Table I ). In spite of the significant catalytic defect in polymerase activity, the retention of near WT exonuclease activity implies that DNA binding by A467T p140 is only slightly reduced. Therefore, we measured the K m(DNA) for the WT and A467T p140 (Table I) . Although the 2-fold increase in K m(DNA) is consistent with the observed 2-fold decrease in exonuclease activity, it cannot fully account for the observed reduction in polymerase activity. Additionally, we measured the K d(DNA) for these two forms of pol g and found a 5-fold increase in K d(DNA) for the A467T p140 as compared to WT (Table I) . These values for A467T p140 are consistent with reduced intrinsic binding affinity for this mutant enzyme (28) .
Low processivity of A467T p140 is not enhanced by p55
Human pol g is composed of a 140 kDa catalytic subunit and a 55 kDa accessory subunit. Each time the catalytic subunit binds productively to a DNA primer-template, it synthesizes 50-100 nucleotides prior t o dissociating from the DNA (23) . Association of the accessory subunit enhances binding of the complex to DNA, thereby reducing dissociation from the primer-template and increasing processivity up to several thousand nucleotides (19) . Functional interaction of A467T p140 with its accessory subunit was tested in a gelbased primer extension assay under conditions that permit multiple binding events ( Fig. 2A) . Isolated WT p140 extends the primer roughly 100 nt at 0 mM NaCl (lanes 1 and 5), and this activity is almost completely inhibited by 0.15 M NaCl (lanes 2 and 6). Distinct pausing due t o template secondary structure at ~50 and ~85 n t was apparent, as previously observed (15, 23) . Addition of the accessory subunit stimulated primer extension at both salt concentrations (lanes 3, 4, 7 and 8). Notably, p55 reduced the exonuclease activity of WT p140 at low salt (compare lanes 5 and 7) yet stimulated this activity at high salt (compare lanes 6 and 8). The greatly diminished catalytic activity of A467T p140 (Table I) did not permit substantial primer extension past the first major pause site (lane 9), and polymerase activity was inhibited by physiological salt concentrations (lane 10). Inclusion of p55 mildly stimulated primer extension by A467T p140 at low salt (lane 11), just as it did for the WT forms of p140. In clear contrast, p55 was incapable of stimulating the polymerase or exonuclease activities of A467T p140 at 0.15 M NaCl (lane 12). The true processivity of each enzyme was revealed in identical reactions that also included a DNA trap (Fig. 2B) , conditions under which the polymerase extends the end-labeled primer, dissociates from the primer-template, and migrates to the unlabeled DNA trap (19) . The overall yield of extended primers was considerably reduced when each enzyme was limited to a single binding event (Fig. 2B ). W T p140 Exo -(lanes 1-4) and WT p140 Exo + (lanes 5-8) generated products only 25-50 nucleotides shorter than those produced with multiple binding events, and stimulation by the p55 accessory subunit was apparent at both 0 mM and 0.15 M NaCl. However, A467T p140 was only able to extend primers by a few nucleotides at low ionic strength prior to dissociation and migration to the DNA trap (lane 9), and stimulation of A467T p140 by p55 was virtually undetectable (lanes 11 and 12). These results suggest that, unlike WT p140, A467T p140 only weakly interacts with p55 at low ionic strength, and this functional association of the subunits is abolished at physiological salt concentrations. A series of experiments were undertaken to further assess both the functional and physical interaction of the two subunits.
p55 differentially stabilizes WT p140 but not A467T p140 against heat inactivation
Pol g activities are exceptionally sensitive to heat inactivation in the absence of a DNA substrate (29) . Accordingly, we evaluated the ability of the accessory subunit to affect the thermostability of the isolated catalytic subunit. When pre-incubated at 42˚C without a primertemplate, the polymerase activity of WT p140 was inactivated with a half-life of approximately 30 s (Fig. 3) . This rate decreased 2-fold upon the addition of p55, indicating that association of the two subunits partially stabilized p140 against heat inactivation.
The polymerase activity of A467T p140 was slightly more stable than WT p140. However, inclusion of p55 did not change the rate of heat inactivation of A467T p140. This failure of p55 to enhance the thermostability of A467T p140 suggests an impaired interaction between the two subunits.
p55 does not protect A467T p140 from attack by N-ethylmaleimide
NEM inhibits certain enzymes, including human pol g, through covalent modification of solvent accessible cysteine residues. Because cysteine has not been identified as a catalytic residue in any DNA polymerase, we presume that modification with NEM inhibits pol g by interfering with formation of a ternary complex between the enzyme, the primer-template, and the incoming dNTP substrate. We previously established that association with its accessory subunit protects the pol g catalytic subunit from inactivation by NEM (19, 30) . This protective effect offers an excellent probe to more finely assess the ability of A467T p140 to associate with the accessory subunit. Inhibition of W T p140 by varying concentrations of NEM was reestablished in the standard pol g polymerase assay in which 0.2 mM NEM inhibited pol g activity by ~90% (Fig. 4) . A 2-fold molar excess of p55 was able to protect >90% of W T polymerase activity at 0.2 mM NEM. Interestingly, A467T p140 was only ~60% inhibited by 0.2 mM NEM. This intermediate susceptibility to inactivation by NEM could result from a subtle alteration of protein conformation that reduces the solvent accessibility of NEM-sensitive site(s) on A467T p140 relative to WT p140. Addition of p55 provided no enhancement of A467T p140 activity, which further supports the notion that p55 only weakly associates with A467T p140 compared to WT p140.
In control experiments, varying the quantity of A467T p140 approximately 8-fold had no effect on the degree of inhibition, the shape of the inhibition curves, and the protective effect of p55.
Wild-type p140 and A467T p140 have different thermolysin digestion patterns
Association of the two subunits was also examined by partial digestion with the thermostable protease thermolysin.
Various temperatures were employed to promote mild denaturation of p140 during proteolytic digestion. Purified WT p140 and A467T p140 were partially digested with thermolysin, and the banding patterns of p140 fragments generated in the presence and absence of p55 were monitored by denaturing gel electrophoresis and immunoblotting methods as described in "Experimental Procedures". In the absence of p55, both WT and A467T p140 exhibited similar patterns of degradation that progressed as the temperature was increased (Fig. 5) . However, inclusion of p55 permitted protection of an ~80 kDa fragment of WT p140 that was degraded in the absence of p55 (Fig. 5, lane 4) . Less of this ~80 kDa fragment accumulated during digestion of A467T p140, and the addition of p55 did not prevent digestion of thẽ 80 kDa intermediate. In short, unlike W T p140, no clear changes in the degradation pattern of A467T p140 were observed upon the addition of p55, which suggests a closer association of p55 to WT p140 than to the mutant form of the enzyme.
Immunoprecipitation assay reveals weak interaction between p140 and p55 subunits
Physical association of the subunits was also assessed by IP assay. Protein G-Sepharose beads were loaded with polyclonal antibodies raised against p140 and used to test the ability of purified WT p140 or A467T p140 to bind p55 under physiological salt conditions. Both forms of p140 were immunoprecipitated with equal efficiency (Fig. 6, lanes 2 and 3) , and WT p140 clearly bound the accessory subunit (lane 4). However, the mutant form of p140 was not able to bind appreciable quantities of p55 (lane 5). This weak subunit interaction helps to explain the inability of p55 both to enhance the processivity of A467T p140 and to protect the mutant enzyme from inactivation by NEM.
DISCUSSION
The A467T amino acid substitution in p140 is associated with a wide range of recessive mitochondrial disorders. One major finding of the current study is the discovery of a specific catalytic deficiency in the DNA polymerase activity of the A467T enzyme, which retains 4% of WT polymerase activity. Previous biochemical characterization of four mutant forms of p140 that cause autosomal dominant by guest on October 30, 2017 http://www.jbc.org/ Downloaded from PEO also revealed catalytic deficiencies, and the mutant enzymes exhibited 0.03-30% of W T polymerase activity (15) . Although the extent of the biochemical defects roughly correlated with the clinical severity of adPEO (15) , the current work indicates that the degree of the catalytic defect in vitro is insufficient to predict recessive or dominant transmission in vivo. In the four dominant cases, each pathogenic amino acid substitution mapped in or near the polymerase active site of p140 within a structural homology model of the pol g polymerase domain (15) .
Since structural information is not available for the linker and exonuclease regions of pol g, the mechanism by which the A467T substitution differentially affects DNA polymerase activity is not entirely clear. However, given that importation of proteins into mitochondria proceeds from the N-terminus to the C-terminus, it is possible that protein conformation distal to the A467T substitution may be affected.
Our second major finding is the failure of A467T p140 to interact functionally or physically with the 55 kDa accessory subunit. When functional association of the subunits was assessed in primer extension assays, p55 only weakly stimulated A467T p140 at low ionic strength, and this interaction was abolished at a physiological salt concentration ( Fig. 2A) . During revision of this manuscript, Luoma, et al. reported reduced DNA binding by A467T p140 Exo -in a gel mobility shift assay and a 2-fold stimulation of A467T p140 Exo -by the p55 subunit in a primer extension assay that permitted multiple DNA binding events (31). Consistent with a reduced affinity for DNA, A467T p140 activity was significantly reduced when limited to a single DNA binding event (Fig.  2B) . However p55 was unable to stimulate the processivity of A467T p140 under these more restrictive conditions (Fig. 2B) . Impaired physical association of the subunits was also demonstrated by NEM protection (Fig. 4) and immunoprecipitation assays (Fig. 6) .
The ability of p55 to alter the thermostability and susceptibility to proteolysis of WT p140 but not A467T p140 also support the conclusion that the A467T substitution interferes with association of the two subunits. The A467T mutant enzyme is the first example of a point mutation in the linker region of the p140 catalytic subunit that affects binding of the p55 accessory subunit. As such, the A467T enzyme offers a unique reagent to more finely map this interaction. In the absence of a crystal structure of the complex, the identification of additional mutants in p140 and p55 that interfere with subunit association will also help to map the subunit interface.
Gene dose is an important determinant of age of onset, as well as the severity and type of disease with which the patient presents. Patients who are homozygous for the A467T mutation have been shown to present with either a later onset Alpers syndrome, SCAE which generally starts in the teens or a syndrome resembling myoclonus, epilepsy, and ragged red fibers (MERRF), which also presented in the teens. Interestingly, these diseases have very different presentations and mtDNA defects. Tissue-specific mtDNA depletion is a clear molecular feature of Alpers syndrome (11, 32) .
An Alpers patient who was homozygous for the A467T mutation presented with symptoms at age 7 and died at 19 years (11). Brain tissue from this patient showed a partial reduction in mtDNA content compared with two control brains (11). SCAE patients who were homozygous for A467T presented with symptoms in their late teens and lived past mid-life (8, 10) .
MtDNA deletions were observed in these patients.
In addition, a homozygous A467T patient presented with MERRF-like syndrome at age 15 exhibited low levels of mtDNA deletions in the muscle (33) . In contrast, those who are heterozygous for the A467T mutation (WT/A467T) do not show any symptoms of disease (5) (6) (7) (8) (9) (10) (11) (12) 33, 34) , although one recent study reported a mild dominant manifestation of late-onset ptosis in a patient heterozygous for the A467T mutation (31). In an extreme example of this gene dose effect, we have recently shown that mono-allelic expression of an A467T allele was linked to a case of Alpers syndrome with early onset at 18 months followed by death at 42 months (35) .
The nature of the mutation in the second POLG allele in compound heterozygous patients also influences the severity and type of disease, ranging from early onset Alpers syndrome to late onset arPEO. For example, many patients with arPEO have one or more POLG mutations in each allele. Those with the A467T mutation in one POLG allele have either the L304R, R3P, G268A, or S1104C POLG mutations in trans and disease onset is later in life (5) (6) (7) 33, 36) .
SANDO patients are also compound heterozygous, with A467T in one POLG allele, and R3P, L304R or R627W in the other (7) .
One patient with SCAE was heterozygous for the A467T mutation, with W748S and E1143G mutations in the other allele.
The latter mutation, E1143G, was originally identified as a SNP in 4% of the general population (2) . One patient with ataxiamyopathy syndrome was shown to have A467T in one POLG allele, with R627Q and Q1236H mutations in the second POLG allele (31). In Alpers syndrome, the A467T mutation was originally identified in a compound heterozygous patient with the E873stop mutation in trans (9) . Since then, the A467T mutation has been identified in 11 out of 14 Alpers pedigrees as either a homozygous or a compound heterozygous mutation in POLG (34) . Children with A467T in trans with either G848S or A957P presented with Alpers symptoms in early life, with death occurring before three years of age (11). One child with A467T in trans with a 3482 splice site mutation presented with the symptoms of Alpers syndrome at 4 years of age and at 13 years is presently in a vegetative state (11). Thus, numerous different diseases are associated with this common A467T substitution in POLG.
This study reveals how the altered function of pol g due to the A467T substitution leads to pathology in Alpers syndrome, SCAE and PEO. The reduced polymerase activity and loss of interaction between the catalytic and accessory subunits promotes marked stalling during DNA synthesis. We propose that people who are heterozygous for A467T (WT/A467T) retain sufficient polymerase function for survival, whereas pol g activity in patients homozygous for the A467T substitution is inadequate to maintain a sufficient quantity of functional mtDNA as the patient ages. This model is consistent with the mtDNA deletions observed in patients with arPEO and SCAE, as well as the mtDNA depletion seen in patients with Alpers syndrome.
Thus, in Alpers syndrome, SCAE or arPEO, the A467T mutant pol g is insufficient for sustained mtDNA replication and patient viability. We propose that reduced polymerase activity and loss of accessory subunit interaction are responsible for the depletion and deletion of mtDNA observed in patients with this POLG mutation.
WT, wild-type; Exo -, exonuclease-deficient; Exo + , exonuclease-proficient; MERRF, myoclonus, epilepsy, and ragged red fibers.
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